Statins for primary prevention: at what coronary risk is safety assured?

AIMS: Increasingly HMG CoA reductase inhibitors (statins) are being used for primary prevention of vascular disease in patients with a raised cholesterol but at low absolute risk of coronary heart disease (CHD). This study uses clinical trial results to explore the limits of absolute safety for stat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jackson, Peter R, Wallis, Erica J, Haq, Ifti U, Ramsay, Lawrence E
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2001
Soggetti:
Pharmacoepidemiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014585/
https://ncbi.nlm.nih.gov/pubmed/11678788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.0306-5251.2001.01478.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi